Stocky
RGEN
Repligen Corporation
NASDAQ NMS - GLOBAL MARKET · Life Sciences Tools & Services · US
158.59
▲ +5.88%

What's happening at Repligen Corporation

Repligen Corporation's latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 29 Jul 2026

Reports second quarter 2026 financial results

Shows how the company is performing financially and helps investors understand if the business is growing.

SEC 10-Q · filed 2026-07-29 View filing ↗
Earnings 28 Jul 2026

Announces second quarter 2026 earnings on July 28

Reveals whether the company made more or less money than expected, affecting its stock value.

SEC 8-K · filed 2026-07-28 View filing ↗
Deal 22 Jul 2026

Agrees to merge with BioLife Solutions

A major deal combining two companies creates a larger business but changes what investors own.

SEC 8-K · filed 2026-07-22 View filing ↗
Governance 15 May 2026

Stockholders elect nine directors and approve auditor

Shows shareholders chose leaders and oversight, which protect investor interests in the company.

SEC 8-K · filed 2026-05-15 View filing ↗
Earnings 6 May 2026

Reports first quarter 2026 financial results

Reveals company performance during the quarter to help investors track if business is improving.

SEC 10-Q · filed 2026-05-06 View filing ↗
Earnings 5 May 2026

Announces first quarter 2026 earnings on May 5

Discloses quarterly profits and losses, which help investors decide if the stock is worth buying.

SEC 8-K · filed 2026-05-05 View filing ↗
Earnings 26 Feb 2026

Files full year 2025 annual report

Complete financial picture for 2025 shows total revenue, costs, and overall health of the business.

SEC 10-K · filed 2026-02-26 View filing ↗

Common questions

How does Stocky track Repligen Corporation's company events?

Stocky reads Repligen Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Repligen Corporation's most recent SEC filing?

Repligen Corporation's most recent tracked filing was a 10-Q on 29 Jul 2026: Reports second quarter 2026 financial results.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Repligen Corporation's full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.